Quinazolinedione derivatives as PARP inhibitors

Details for Australian Patent Application No. 2005259190 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Wouters, Walter Boudewijn Leopold; Van Dun, Jacobus Alphonsus Josephus; Somers, Maria Victorina Francisca; Mertens, Josephus Carolus; Kennis, Ludo Edmond Josephine

Agent Shelston IP

Pub. Number AU-B-2005259190

PCT Pub. Number WO2006/003148

Priority 04076885.5 30.06.04 EP

Filing date 28 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 12 May 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/003148 Priority application(s): WO2006/003148

12 May 2011 Application Accepted

  Published as AU-B-2005259190

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259192-Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors

2005259189-Phthalazine derivatives as PARP inhibitors